title: FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.
authors.affiliation: Department of Chest Medicine, Erasme Hospital, Brussels, Belgium.
authors.forename: C
authors.initials: C
authors.lastname: Knoop
authors.forename: M
authors.initials: M
authors.lastname: Antoine
authors.forename: J L
authors.initials: JL
authors.lastname: Vachiéry
authors.forename: J C
authors.initials: JC
authors.lastname: Yernault
authors.forename: M
authors.initials: M
authors.lastname: Estenne
mesh_terms: D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D016041:Heart-Lung Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012129:Respiratory Function Tests; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone